SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-047371
Filing Date
2017-09-11
Accepted
2017-09-11 08:00:17
Documents
18
Period of Report
2017-09-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v474892_8k.htm 8-K 16213
2 EXHIBIT 99.1 v474892_ex99-1.htm EX-99.1 21094
3 GRAPHIC image_001.jpg GRAPHIC 49383
4 GRAPHIC image_002.jpg GRAPHIC 176063
5 GRAPHIC image_003.jpg GRAPHIC 93750
6 GRAPHIC image_004.jpg GRAPHIC 63541
7 GRAPHIC image_005.jpg GRAPHIC 90640
8 GRAPHIC image_006.jpg GRAPHIC 91846
9 GRAPHIC image_007.jpg GRAPHIC 68738
10 GRAPHIC image_008.jpg GRAPHIC 65309
11 GRAPHIC image_009.jpg GRAPHIC 78721
12 GRAPHIC image_010.jpg GRAPHIC 99196
13 GRAPHIC image_011.jpg GRAPHIC 99255
14 GRAPHIC image_012.jpg GRAPHIC 91928
15 GRAPHIC image_013.jpg GRAPHIC 93685
16 GRAPHIC image_014.jpg GRAPHIC 91130
17 GRAPHIC image_015.jpg GRAPHIC 75865
18 GRAPHIC image_016.jpg GRAPHIC 105101
  Complete submission text file 0001144204-17-047371.txt   2016132
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15281 | Film No.: 171077972
SIC: 2836 Biological Products, (No Diagnostic Substances)